TECHBio-Techne

$72.47+37% 1Y

Is it growing?

Good

Growing: earnings up +150% year on year and operating margin widening (+12.0 points).

2 good, 1 neutral
Revenue trend−0% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +5% a year.

Earnings trend+150% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+12.0 points operating

Trailing-twelve-month operating margin, 20.6% now against 8.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbehind 68% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TECH growing?

Bio-Techne has grown revenue 2.3% a year over three years and 5.5% a year over five, with earnings per share compounding at −13%.

+2.3%

Revenue growth, 3-year annual rate · Biotechnology median +17% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+5.5%

Revenue growth, 5-year rate · +2.3% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
−13%

Earnings per share, 3-year rate · revenue +2.3% · earnings lagged revenue: the growth is costing something

Years of annual history on file
18

Years of annual history on file · FY2009 to FY2026, as filed

Details›
Revenue FY2022
$1.11B
Revenue FY2023
$1.14B
Revenue FY2024
$1.16B
Revenue FY2025
$1.22B
Revenue FY2026
$1.22B

Annual income statements as filed with the SEC.

On our screens:Stocks with no debt